The main delay was the CMS approval. That approval now applies to the pivotal study which should help avoid any delays we have had. The target is to release data at TCT in late OCT. despite delays we are still on track for that.
AVR Price at posting:
$21.48 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)